Phase II trials and stem cell therapies
Read time: 10 mins
Last updated:2nd Sep 2020
Published:2nd Sep 2020
What drug therapies on the horizon for NASH? Discover range of treatments currently in phase II trials and the trials that didn’t make it to phase III. Also learn about the potential for stem cell therapies in treating NASH.
There are more than a dozen or so treatments in Phase II trials, including agonists for PPAR and farnesoid X receptors, such as Enanta’s EDP 305.